AI-generated summary
The authors compared 308-nm monochromatic excimer light alone with the same light plus topical tacalcitol in 38 patients with vitiligo, using a single-blind, within-patient design. They report that the combination produced more excellent repigmentation (25.7% vs. 5.7%) and reached initial repigmentation with a lower cumulative dose. The abstract notes that total response rates did not differ significantly between the two sides.
- Participants
- 38
- Who or what was studied
- Patients with vitiligo
- Wavelengths
- 308 nm
- Limits stated in the abstract
- The abstract reports a single-blind, within-patient trial design, and total response did not differ significantly between sides, so the advantage is limited to excellent repigmentation and dosing.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Energy density (fluence)
- 0.59 J/cm2, 0.68 J/cm2
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.